[Federal Register Volume 87, Number 146 (Monday, August 1, 2022)]
[Notices]
[Pages 46970-46972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16346]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Appointment to the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS) is
soliciting nominations of individuals who are interested in being
considered a voting member or non-voting liaison member for appointment
to the Presidential Advisory Council on Combating Antibiotic-Resistant
Bacteria (Advisory Council). Nominations from qualified individuals who
wish to be considered for appointment to either of these member
categories of the Advisory Council are currently being accepted.
DATES: Nominations must be received no later than 12:00 a.m. ET on
September 19th, 2022.
ADDRESSES: Information on how to submit a nomination is on the Advisory
[[Page 46971]]
Council website, https://www.hhs.gov/ash/advisory-committees/paccarb/index.html.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, MS, Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room 715H, Hubert H. Humphrey
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone:
(202) 746-1512; email: [email protected]. The Advisory Council charter may
be accessed online at https://www.hhs.gov/ash/advisory-committees/paccarb/about-paccarb/charter/index.html. The charter includes detailed
information about the Advisory Council's purpose, function, and
structure.
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (Advisory Council), established
by Executive Order 13676, is continued by Section 505 of Public Law
116-22, the Pandemic and All-Hazards Preparedness and Advancing
Innovation Act of 2019 (PAHPAIA). Activities and duties of the Advisory
Council are governed by the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. app.),
which sets forth standards for the formation and use of federal
advisory committees.
The Advisory Council shall provide information and recommendations
to the Secretary of Health and Human Services (Secretary) regarding
programs and policies intended to reduce or combat antibiotic-resistant
bacteria that may present a public health threat and improve
capabilities to prevent, diagnose, mitigate, or treat such resistance.
The Advisory Council shall function solely for advisory purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advance
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States'
capabilities to combat antibiotic resistance.
The Advisory Council is authorized to consist of at least 30
members, including the voting and non-voting members and the Chair and
Vice Chair. The current composition of the Advisory Council consists of
15 voting members, including the Chair and Vice Chair, eight non-voting
liaison representative members, and 12 non-voting ex-officio members.
This announcement is to solicit nominations to fill 16 positions
that are scheduled to be vacated during the 2023 calendar year, nine of
which are in the voting member category while the remaining seven are
in the non-voting liaison member category. Newly appointed voting
members are appointed to serve four year terms, and non-voting liaison
members are appointed to serve for two year terms.
The nine voting members sought for this solicitation will be
selected from individuals who are engaged in: research on, or
implementation of, interventions regarding efforts to preserve the
effectiveness of antibiotics by optimizing their use; advancing
research to develop improved methods for combating antibiotic
resistance and conducting antibiotic stewardship; strengthening
surveillance of antibiotic-resistant bacterial infections; preventing
the transmission of antibiotic-resistant bacterial infections;
advancing the development of rapid point-of-care and agricultural
diagnostics; furthering research on new treatments for bacterial
infections; developing alternatives to antibiotics for agricultural
purposes; maximizing the dissemination of up-to-date information on the
appropriate and proper use of antibiotics to the general public and
human and animal health care providers; and improving international
coordination of efforts to combat antibiotic resistance.
The voting members will represent balanced points of view from
human biomedical, public health, One Health, global antimicrobial
resistance, environmental microbiology, animal agriculture (e.g.,
poultry, cattle, swine, aquaculture), and crop agricultural fields. The
voting members may be physicians (e.g., infectious disease
specialists), veterinarians (e.g., companion animal, food-animal), crop
scientists, epidemiologists, microbiologists, or other health care
professionals (e.g., nurses, pharmacists, others); individuals who have
expertise and experience as consumer or patient advocates concerned
with antibiotic resistance; individuals in the fields of agriculture
and pharmaceuticals; and/or they also may be from state or local health
agencies or public health organizations. The voting members will be
appointed by the Secretary. All voting members will be classified as
special government employees (SGEs).
The seven non-voting liaison representatives are selected from
organizations and/or interest groups that are involved in the advocacy,
education, development, testing, licensing, production, procurement,
distribution, and/or use of antibiotics and/or antibiotic research.
Non-voting liaison representative members shall possess knowledge,
skills, experience, and expertise necessary to inform the Advisory
Council in generating intelligent recommendations with respect to the
issues mandated by PAHPAIA. Individuals from the following sample
sectors are being sought to serve as non-voting liaison
representatives: (1) professional organizations or associations
representing providers, professionals, or specialists (e.g., long-term
care, outpatient) for human and/or animal health involved in infection
control and prevention, antimicrobial stewardship, or antimicrobial
resistance and use; this can include but is not limited to physicians,
nurses, pharmacists, microbiologists, veterinarians, or scientists; (2)
public health, environmental health, and/or animal health organizations
or associations (state/territorial, county, or local) representing
laboratories, health officials, epidemiologists, agricultural state
departments, hospitals, or environmental associations; (3) other
organizations representing patients and consumer advocates, hospitals,
pharmaceutical industry, global health, food producers and retailers,
or other commodity groups.
Individuals who are appointed to serve as voting and non-voting
liaison members may be allowed to receive per diem and reimbursement
for any applicable expenses for travel that is performed to attend
meetings of the Advisory Council as authorized by 5 U.S.C. 5703, for
persons employed intermittently in the Government service. The Advisory
Council meets, at a minimum, two times per year depending on the
availability of funds. Meetings are open to the public, except as
determined otherwise by the Secretary, or other official to whom the
[[Page 46972]]
authority has been delegated, in accordance with guidelines under the
Sunshine Act, 5 U.S.C. 552b(c).
Every effort will be made to ensure that the membership of federal
advisory committees is diverse, equitable, and fairly balanced in terms
of the expertise represented. Detailed information on what is required
in a nomination package and how to submit one is on the Advisory
Council website, https://www.hhs.gov/ash/advisory-committees/paccarb/index.html.
B. Kaye Hayes,
Deputy Assistant Secretary for Infectious Disease, Director, Office of
Infectious Disease and HIV/AIDS Policy (OIDP), Executive Director,
Presidential Advisory Council on HIV/AIDS (PACHA).
[FR Doc. 2022-16346 Filed 7-29-22; 8:45 am]
BILLING CODE 4150-44-P